Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit

被引:65
作者
Okabayashi, K
Wada, H
Ohta, S
Shiku, H
Nobori, T
Maruyama, K
机构
[1] Mie Univ, Sch Med, Dept Lab Med, Tsu, Mie 5148507, Japan
[2] Mie Univ, Sch Med, Dept Internal Med 2, Tsu, Mie 5148507, Japan
[3] Mie Univ, Sch Med, Dept Anesthesiol, Tsu, Mie 5148507, Japan
关键词
hemostatic markers; sepsis-related organ failure; disseminated intravascular coagulation; DIC; intensive care;
D O I
10.1002/ajh.20089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the correlation between disseminated intravascular coagulation (DIC) score and hemostatic parameters and sepsis-related organ failure assessment (SOFA) score with clinical outcome of patients with DIC in an intensive care unit (ICU). The SOFA score was markedly elevated in patients with DIC relative to patients without DIC and significantly higher in non-survivors than in survivors. Abnormalities in almost all hemostatic parameters were significant in patients with DIC, but there was no significant difference in almost all hemostatic parameters between survivors and non-survivors. However, plasma antithrombin (AT) levels were significantly lower in non-survivors than in survivors. Soluble fibrin (SF) and tissue type plasminogen activator (tPA)-plasminogen activator inhibitor-I (PAI-I) complex correlated significantly with the SOFA score, whereas AT levels correlated significantly and negatively with the SOFA score. We conclude that the SOFA score is useful for predicting outcome in DIC patients in the ICU, and that hemostatic parameters, especially plasma AT levels, are also useful markers for organ failure and clinical outcome. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:225 / 229
页数:5
相关论文
共 28 条
[1]   Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis - Question and answer session after scientific review [J].
Vincent, JL ;
Abraham, E ;
Esmon, C ;
Hack, CE .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S33-S33
[2]   MULTIPLE ORGAN FAILURE SYNDROME IN THE 1990S - SYSTEMIC INFLAMMATORY RESPONSE AND ORGAN DYSFUNCTION [J].
BEAL, AL ;
CERRA, FB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :226-233
[3]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[4]   DISSEMINATED INTRAVASCULAR COAGULATION AND RELATED SYNDROMES - A CLINICAL REVIEW [J].
BICK, RL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1988, 14 (04) :299-338
[5]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[6]  
Esmon CT, 2001, THROMB HAEMOSTASIS, V86, P51
[7]   Clinical trial results with antithrombin III in sepsis - Question and answer session after scientific review [J].
Vincent, JL ;
Fourrier, F ;
Opal, S .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S43-S43
[8]   Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome [J].
Gando, S ;
Kameue, T ;
Nanzaki, S ;
Hayakawa, T ;
Nakanishi, Y .
CRITICAL CARE MEDICINE, 1997, 25 (11) :1820-1826
[9]  
Gando S, 1996, THROMB HAEMOSTASIS, V75, P224
[10]  
KOBAYASHI N, 1987, BIBL HAEMATOL, V49, P265